Written Question·Department of Health and Social Care·UIN 34170
Pancreatic Enzyme Replacement Therapy: Drugs
Tabled: 26 February 2025
Answered: 7 March 2025
Question
Edward Morello
Liberal Democrat — West Dorset
To ask the Secretary of State for Health and Social Care, what discussions his Department has had with pharmaceutical manufacturers on resolving supply chain issues with pancreatic enzyme replacement therapy medications; and what his planned timetable is
Answer
Karin SmythThe Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to boost production to mitigate the supply issue. Through this work we have managed to secure additional volumes of PERT for 2025. The Department has...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 34170) →